$10 million gift from Brock family to establish Brock Family Center for Applied Innovation

Steaban receives Outstanding Operational Partner Award

Steaban, MSN, RN, NEA-BC, received the Outstanding Operational Partner Award during the Vanderbilt Symposium on Implementation Research in the Learning Health System.

Major grant renewal to provide five more years of support for VICTR

Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health.

Pandemic leads to broader use of monoclonal antibodies

Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.

Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Long-acting antibody combo developed at VUMC reduces COVID-19 risk and symptoms